Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: J Pain Symptom Manage. 2012 Jun 13;44(3):362–372. doi: 10.1016/j.jpainsymman.2011.09.017

Table 3.

Prevalence of Pharmaceutical Prescribing for Symptoms, and Summary of Concordance of Pharmaceutical Prescribing and Symptom Documentation in the Medical Record for the Sample of n=384 Women

Symptom Prevalence of Pharmaceutical Prescribing % Rate of Pharmaceutical Prescribing When Symptom Was Documented Kappa for Agreement Between Symptom Documentation and Pharmaceutical Prescribing % Agreement Between Symptom Documentation and Pharmaceutical Prescribing Positive Agreement % Negative Agreement % McNemar’s Test P-value a
Dyspnea 1.82 10.53 0.16 86 19 93 <0.0001
Diarrhea 3.39 33.33 0.47 93 50 96 <0.0001
Insomnia 3.39 34.21 0.48 93 51 97 <0.0001
Fatigue 4.17 10.13 0.12 63 18 76 <0.0001
Pain 23.44 62.14 0.66 85 76 90 <0.0001
Vomiting 2.34 36.00 0.51 96 53 98 <0.0001
Nausea 15.10 71.43 0.78 93 81 96 <0.0001
Poor appetite 2.34 27.59 0.40 94 42 97 <0.0001
Constipation 8.07 50.00 0.61 92 65 95 <0.0001
Mouth Sores 2.86 45.45 0.59 97 61 98 <0.0001
Dry mouth 0.26 20.00 0.33 99 33 99 0.0455
Cough 2.34 32.14 0.47 95 49 97 <0.0001
a

Disagreement was significant for all symptoms except dry mouth based on Bonferroni adjusted alpha of 0.004.